Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
We have never been closer to cracking cancer. MIT Startup Exchange, in collaboration with the MIT Koch Institute, is convening the 2nd annual Cracking Cancer event to discuss the latest advances in cancer innovation from the perspective of industry, academia, venture, and startups in the MIT ecosystem.
Broad-acting Peptide Conjugate Antiviral Platform
Barbara Hibner; Co-Founder and CSO, Decoy Therapeutics